The Global Sertraline Market was valued at US$ 7.4 billion in 2024 and is projected to reach US$ 9.8 billion by 2032, growing at a CAGR of 3.7% from 2024 to 2032. The increasing prevalence of mental health disorders and rising awareness about antidepressants are key factors driving market growth Sertraline is a widely used selective serotonin reuptake inhibitor (SSRI) that primarily treats major..